Lead Product(s) : Amiselimod HCl
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : MT-1303 (amiselimod HCl) is a sphingosine-1-phosphate receptor functional antagonist, which is being evaluated in Phase II clinical trial studies with patients for the treatment of ulcerative colitis.
Product Name : MT-1303
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 21, 2023
Lead Product(s) : Amiselimod HCl
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : QBECO-SSI
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Karolinska Institute
Deal Size : Undisclosed
Deal Type : Collaboration
Details : QBECO-SSI treatment, which is designed to restore normal innate immune function, immune homeostasis, and barrier function in the GI tract, provides a novel potentially transformative alternative to immunosuppressive therapies for patients living with IBD...
Product Name : QBECO-SSI
Product Type : Vaccine
Upfront Cash : Undisclosed
December 14, 2022
Lead Product(s) : QBECO-SSI
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Karolinska Institute
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : QBECO-SSI
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : $12.0 million
Deal Type : Financing
Qu Biologics Closes USD$12M Equity Financing
Details : This new equity funding that will allow team and play an essential role in initiating three new Phase 2 randomized placebo-controlled clinical studies of Qbeco. Two of these important trials are in critical indications for which there are no effective tr...
Product Name : QBECO-SSI
Product Type : Vaccine
Upfront Cash : Undisclosed
March 21, 2022
Lead Product(s) : QBECO-SSI
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : $12.0 million
Deal Type : Financing